万维书刊网微信二维码

扫微信,关注编辑QQ!

您的位置:万维书刊网 >>ssci期刊 >>公卫医学类>>护理学
您的位置:万维书刊网 >>sci/e期刊大全 >>医药卫生2>>护理

COLLEGIAN《澳大利亚护理实践、学术与研究杂志》 (官网投稿)

简介
  • 期刊简称COLLEGIAN
  • 参考译名《澳大利亚护理实践、学术与研究杂志》
  • 核心类别 SSCI(2023版), SCIE(2023版), 外文期刊,
  • IF影响因子
  • 自引率9.90%
  • 主要研究方向医学-NURSING 护理

主要研究方向:

等待设置主要研究方向
医学-NURSING 护理

COLLEGIAN《澳大利亚护理实践、学术与研究杂志》(双月刊). Collegian: The Australian Journal of Nursing Practice, Scholarship and Research is a refereed journal with ...[显示全部]
征稿信息

万维提示:

1、投稿方式:在线投稿。

2、期刊网址:https://www.collegianjournal.com/

https://www.journals.elsevier.com/collegian/

3、投稿网址:

https://www.editorialmanager.com/coll//default.aspx

4、官网邮箱:Collegian@acn.edu.au

5、官网电话:02 6283 3400

6、期刊刊期:双月刊,逢双月出版。

202167日星期一

                              


投稿须知【官网信息】

 

Guide for Authors

Aims and scope

Collegian: The Australian Journal of Nursing Practice, Scholarship and Research is a refereed journal with an Editorial Board that meets high standards of academic and clinical expertise. The journal reflects the broad interests of nurses and the nursing profession. Papers are invited on contemporary clinical, professional and policy issues of interest to nurses such as:

Original clinical and educational research

Scholarly critique of policy and nursing issues

Clinical case reports

Historical or political critique of nursing and health care issues

In addition, Collegian: The Australian Journal of Nursing Practice, Scholarship and Research seeks to promote nursing through publication of reviews, nursing commentaries and letters.

Considerations specific to types of research designs

The editors require that manuscripts adhere to recognised reporting guidelines relevant to the research design; Randomised Control Trials, Cohort Studies, Observational studies, Non-randomised evaluations and qualitative research. Please submit a completed checklist from the appropriate reporting guidelines as an addendum to your covering letter to the editor.

Observational cohort, case control and cross sectional studies - STROBE - Strengthening the Reporting of Observational Studies in Epidemiology http://www.equator-network.org/

Quasi-experimental/non-randomised evaluations - TREND - Transparent Reporting of Evaluations with Non-randomized Designs http://www.equator-network.org/

Randomised (and quasi-randomised) controlled trial - CONSORT - Consolidated Standards of Reporting Trials http://www.equator-network.org/

Study of Diagnostic accuracy/assessment scale - STARD - Standards for the Reporting of Diagnostic Accuracy Studies http://www.equator-network.org/

Systematic Review of Controlled Trials - PRISMA - Preferred Reporting Items for Systematic Reviews and Meta-Analyses http://www.equator-network.org/

Systematic Review of Observational Studies - MOOSE - Meta-analysis of Observational Studies in Epidemiology http://www.equator-network.org/

Qualitative researchers are encouraged to consult the guideline listed below:

Qualitative studies - COREQ - Consolidated criteria for reporting qualitative research. Tong, A., Sainsbury, P., Craig, J., 2007. Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups. International Journal for Quality in Health Care 19 (6), 349-357.http://intqhc.oxfordjournals.org/content/early/2007/09/14/intqhc.mzm042

Ethics in Publication

This journal follows the Committee of Publication Ethics (COPE) guidelines and requests authors to familarise themselves with these guidelines at: http://publicationethics.org/resources/guidelines. A few issues that authors need to pay particular attention to are set out below.

It is ethically questionable to break up or segment data from a single study to create different papers for publication, a practice called salami slicinga™. If the authors have legitimate reasons for reporting separately on different parts of the same study, or the same data set, they should justify that to the editor at the time of submission. Equally, readers need to be aware that different aspects of the same study are being reported, thus the methods section of the submitted manuscript must clearly explain why the submitted paper is justified.

Double-blind Peer review process

Editors review all abstracts and using a triage-type checklist will make a rapid decision about whether the article is suitable for peer review in this journal. The overall rejection rate at this stage is approximately 60% and the majority of these happen at the rapid decision stage. This rapid decision is of benefit for authors because if the paper is rejected reasons will be given and the author can consider whether to submit elsewhere without undue delay.

The most common reasons for initial rejection are:

1) not having prior institutional ethical approval for research and/or not demonstrating fully informed and fully free consent by participants;

2) not situating the research in the existing literature;

3) poor English and;

4) not following this guide for authors.

Language (usage and editing services)

Please write your text in good English (British usage is accepted). Authors who feel their English language manuscript may require editing to eliminate possible grammatical or spelling errors and to conform to correct scientific English may wish to use the English Language Editing service available from Elsevier's Author Services.

Review Criteria

Each paper that the editor/s assess as suitable for peer review is allocated to two reviewers who are asked to assess the paper against one of the Journal's three sets of reviewing criteria:

Articles submitted for review must be original works, and may not be submitted for review elsewhere whilst under review for the Journal.

After review, the Editor-in-Chief will inform the corresponding author on whether the paper has been accepted, rejected, or needs revision.

Categories of decision

Accept

Minor revisions (accept with revisions as advised by Editors)

Major revisions (possible acceptance following major revision and resubmission)

Reject

All efforts are made to provide fair and thorough reviews as speedily as possible. If an author(s) believes that a manuscript has been wrongly rejected, a detailed appeal letter that responds point-by-point to the reviewers' comments should be sent to the Editor who, after having reviewed the referees' reports, will make the final decision.

Reviewed by Editor-in-Chief or Editorial Team only

Letter to the Editor or a short comment on any topic of current interest

For these types of submissions, the corresponding author will receive a fairly rapid decision on publication.

Production

Following acceptance of a manuscript; it will be transmitted to Elsevier's Production department.

The corresponding author will receive an acknowledgement. The paper will then be edited to comply with house style, and typeset.

The Publisher will email a proof to the corresponding author for checking before it is published.

The corresponding author is responsible for checking proofs thoroughly. By approving the proofs any editorial changes are being accepted.

Submission of Manuscripts

All manuscripts, correspondence and editorial material for publication is submitted online at https://www.editorialmanager.com/coll/default.aspx simply need to "create a new account" (i.e., register) by following the online instructions, and using their own e-mail address and selected password. Authors can then submit manuscripts containing text, tables, and images (figures) online.

Authors can expect an initial decision, ie. to undergo peer-review, Accept or Reject on their submission within 7 business days.

Once a manuscript is accepted for publication, authors can expect web publication of the article in final version on ScienceDirect in 4 weeks.

Preparation of Manuscript

Manuscripts being submitted should not exceed more than 5000 words. For a standard discussion, review, clinical paper or quantitative research articles, the maximum length is 30 double-spaced pages, with standard margins of 2.5 cm (1 inch) all around, and 11 point font size. (Inclusive of all Tables, Figures, and References, but excluding the Structured Abstract).

Supplementary material may be added without specific page limits. The readability of the article, however, must not depend upon access to supplementary materials.

First time authors are also strongly advised to co-author with an academic supervisor or senior colleague who has been successful in writing for publication.

Authors who feel their English language manuscript may require editing to eliminate possible grammatical or spelling errors and to conform to correct scientific.English may wish to use the English Language Editing service available from Elsevier'sWebShop (http://webshop.elsevier.com/languageediting/) or visit our customer support site(https://service.elsevier.com) for more informationPage numbers and line numbers should be included for the convenience of the peer-reviewers.

Please have the following items ready before you log-on to the system. Every submission, regardless of category, must include the following.

 

(1) A Cover letter, including An Author Agreement stating:

o that the article is the author(s) original work

o the article has not received prior publication and is not under consideration for publication elsewhere

o that all authors have seen and approved the manuscript being submitted

o the author(s) abide by the copyright terms and conditions of Elsevier and the Australian College of Nursing

Conflict of Interest:

when the proposed publication concerns any commercial product, either directly or indirectly, the author must include in the cover letter a statement (1) indicating that he or she has no financial or other interest in the product or distributor of the product or (2) explaining the nature of any relation between himself or herself and the manufacturer or distributor of the product. Other kinds of associations, such as consultancies, stock ownership, or other equity interests or patent-licensing arrangements, also must be disclosed. If, in the Editor's judgment, the information disclosed represents a potential conflict of interest, it may be made available to reviewers and may be published at the Editor's discretion; authors will be informed of the decision before publication.

o Sources of outside support for research:

including funding, equipment, and drugs.

An Ethical Statement for all Research papers, providing the following information:

o Whether the submitted manuscript involved human or animal research.

o If human or animal research was involved, whether Ethical Approval was granted for the Study as either (A) A quality assurance or practice improvement project, OR(B) A scientific research study. Note that research studies that do not have ethical approval prior to being conducted will not normally be published. We will consider publication, however, if the relevant Institutional Ethics Committee provides you with a letter saying that they do not normally provide ethical approval for studies such as the one you conducted.

o If the submitted manuscript is based on a research study which was subjected to a full review by an institutional ethics committee, please provide the following information:

- The name of the ethics committee

- The approval number

- The date of approval

Note: If the manuscript is based on a quality assurance or practice improvement project this must be made clear in the text of the paper and address ethical issues concerning informed and free consent and confidentiality, as relevant.

If an Ethical Statement is not applicable, this must also be specified.

(4) Title Page should contain:

o Title. Short (12 words or fewer) and descriptive of the content of the article.

Abbreviations must not be used in the title.

……


  • 万维QQ投稿交流群    招募志愿者

    版权所有 Copyright@2009-2015豫ICP证合字09037080号

     纯自助论文投稿平台    E-mail:eshukan@163.com


投稿问答最小化  关闭